Waregem, 6 October 2008 – In accordance with the stipulations of article 29 of the Act of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Arseus informs that it has received the following three notifications of shareholding (situation on 1 September 2008):
- Fortis Investment Management SA
- Omega Pharma NV
- Couckinvest NV / Coucke
2,756,357 voting rights
7,500,000 voting rights
3,858,080 voting rights
Based on these notifications and the denominator of 31,195,121 (total number of voting rights), the structure of the shareholding is as follows:
Fortis Investment Management SA
8.84%
Omega Pharma NV
24.04%
Couckinvest NV / Coucke
12.37%
Public
54.75%
The original notification forms are also available on the corporate website (www.arseus.com).
This is a translation of the Dutch press release; the Dutch press release prevails.
For further information:
Constantijn van Rietschoten, Investor Relations Manager
+31 6 536 91 585 (mobile)